Anti-inflammatory activity of a crude extract of Piper magnibaccum (Piperaceae) and of compounds isolated from it was established using the TPA-induced mouse ear edema model and an in vitro quantitative lipoxygenase inhibition assay. Five compounds were isolated from P. magnibaccum [β-sitosterol, N-isobutyl-(2E,4E)-tetradecadienamide, linoleic acid, 13-(4', 5'-dimethoxytridecanoyl)piperidine, and piperine]. The light petroleum extract of the plant exhibited significant anti-inflammatory activity in both models. N-isobutyl-(2E,4E)-tetradecadienamide showed significant activity, with an IE % value of 70.2 + 5.4 in the TPA-induced mouse ear edema model and 87.2 + 0.11 in the in vitro quantitative lipoxygenase inhibition assay.
The family Piperaceae is of great interest owing to the variety of biological properties displayed by species in the family. The genus Piper, although rich in terms of numbers of compounds isolated from various species, has not been adequately investigated [1] .
P. magnibaccum C. DC., collected from Indonesia, is a robust climbing plant, reaching up to 10 m, with a rounded stem, 1-1.5 cm in diameter [2] . There is no record of folkloric medicinal use of this plant. In this paper, we report the chemical constituents of this plant and evaluation of their anti-inflammatory activities using a TPA-induced mouse ear edema model and an in vitro quantitative lipoxygenase inhibition assay.
All the compounds reported are new records for this plant. Five compounds have been isolated and characterized, based on their spectroscopic data, as β-sitosterol (1) [3] , N-isobutyl-(2E,4E)tetradecadienamide (2) [4] , linoleic acid (3) [5], 13-(4',5'-dimethoxytridecanoyl)piperidine (4) and piperine (5) [6] . 2-(4-Methoxyphenyl)-3-methyl-5-(E)-propenylbenzofuran, 2,3-dihydro-2-(4hydroxyphenyl)-3-methyl-5-(E)-propenylbenzofuran and 2-(4-hydroxyphenyl)-3-methyl-5-(E)-propenylbenzofuran have been isolated previously from the same species collected in Malaysia [7] .
The isolated compounds and the light petroleum extract obtained from the leaves of P. magnibaccum, when tested in two anti-inflammation assays (TPAinduced mouse ear edema model, topical application 2 mg/ear, and in vitro quantitative lipoxygenase inhibition assay, concentration 100 μg/mL) gave different results. Results showing an inhibitory effect (IE) greater than 50% are considered to have significant activity. The compounds isolated from the light petroleum extract also gave different results depending on the assay used. Compounds (2), (4) and (5) produced percent inhibition of 70.2 + 5.4, 49.1 + 2.9 and 55.6 + 7.6, respectively, while no activity was observed when compounds (1) and (3) were administered topically in the TPA-induced mouse ear edema model. In the in vitro quantitative lipoxygenase inhibition assay, only compound (2) exhibited a high inhibition effect (87.2 + 0.11 at a dose 25 μg/mL), followed by compound (4) with a moderate inhibition effect (59.3 + 0.25); no activity was observed for compounds (1), (3) and (5).
In the histological analysis, topical application of TPA induced the production of tumor necrosis factor (TNFα) and phospholipase A 2 , which convert membrane phospholipids into arachidonic acid (AA), which initiates the complex enzymatic pathway for generating the inflammatory process [8] . The production of TNFα and AA are blocked by an inhibitor protein kinase C (PKC) or phospholipase A 2 inhibitor.
In the TPA-induced mouse ear edema model, the light petroleum extract, and compounds (2), (4) and (5) act as an inhibitor of either protein kinase C or phospholipase A 2 . On the other hand, lipoxygenase is involved in AA metabolism, generating various biologically active leukotrienes that play an important role in inflammation. Inhibition of leukotrienes synthesis in the lipoxygenase pathway may contribute to the anti-inflammatory activity [9] . This mechanism explains how the light petroleum extract, and amides (2) and (4) act as antiinflammatory agents in the in vitro quantitative lipoxygenase inhibition study.
In the present study, it is possible to conclude that the activity of the light petroleum extract may be due to the synergistic effect contributed by the isolated compounds. However, further study is necessary to assess the interaction of both extract and isolated compounds with other experimental models in order to verify their mechanisms of action.
Experimental
Plant material: P. magnibaccum was collected from Tahura Bung Hatta, Padang, West Sumatra, Indonesia, in May 2006 at 100 m above sea level. The plant was identified by Rusdi Tamin and Nurainas MSi. A voucher specimen (EM-04-0506) was deposited at the Herbarium University of Andalas, Padang.
Isolation and purification:
Air dried and powdered leaves (800 g) were extracted with light petroleum followed by removal of the solvent in vacuo; 11.7 g (1.46 %) extract was afforded. Fractionation and purification of this extract by vacuum liquid chromatography and multiple column chromatography afforded five isolated compounds. The structural elucidation of these compounds was based on their spectroscopic data and by comparison of these with the literature. 
Drugs and chemicals used:

TPA-induced mouse ear edema model:
The TPAinduced mouse ear edema assay was carried out according to Gschwendt et al., [10] and Hirota et al., [11] , with little modification. A 25 μg mL -1 stock solution of TPA was prepared in acetone. The test extract and isolated compounds were dissolved in acetone to form a concentration of 50 mg mL -1 . A volume of 40 μL (equivalent to 2 mg extract and 0.5 mg of isolated compound) of the stock extract and isolated compounds was applied topically to the Anti-inflammatory activity of Piper magnibaccum. Natural Product Communications Vol. 3 (10) 2008 1721 the right ear of a mouse while the same volume of acetone was applied to the left ear. Inflammation was induced by painting both ears with 20 μL (equivalent to 0.5 μg TPA) of the TPA stock solution, 40 min after the application of either the test extract or isolated compound. After 6 h, the mice were killed by cervical dislocation and disks of 7 mm diameter were punched and removed from each ear and the weight was determined. The inflammation was measured as the difference in weight between the punches from right and left ears, and expressed as an increase in ear thickness.
In vitro quantitative lipoxygenase inhibition assay:
Lipoxygenase inhibiting activity was conveniently measured by slightly modifying the spectrometric method developed by Tappel [12] and Haq et al., [13] . The assay protocol; 160 μL of 100 mM sodium phosphate buffer (pH 8.0), 10 μL of test compound solution and 20 μL of lipoxygenase solution were mixed and incubated for 10 min at 25 o C. The reaction was then initiated by the addition of 10 μL linoleic acid (substrate) solution and the change in absorbance at 234 nm was followed for 6 min. The test compound and the positive control were dissolved in ethanol. All the reactions were performed in triplicate using a 96-well micro-plate, incubated for 10 min and measured with SpectraMax 384 Plus (Molecular Devices, USA) Statistical analysis: Results were expressed as mean + standard deviation obtained from five mice in the TPA-mouse ear edema model and from three samples in in vitro quantitative lipoxygenase assay.
